Cost-minimisation analysis of pegylated liposomal doxorubicin hydrochloride versus topotecan in the treatment of patients with recurrent epithelial ovarian cancer in Spain

por Ojeda, B, de Sande, L M, Casado, A, Merino, P, Casado, M A
Publicado 2003

Assessing the Construct Validity and Internal Reliability of the Screening Tool Test Your Memory in Patients with Chronic Pain

por Ojeda, B., Salazar, A., Dueñas, M., Torres, L. M., Mico, J. A., Failde, I.
Publicado 2016

SOLTI (Solid Tumor Intensification) Group experience with high-dose chemotherapy treatment for early breast carcinoma

por Funes, H Cortés, Lluch, A, Climent, M, López, JJ, Ojeda, B, Hornedo, J, Ciruelos, E, Baselga, J
Publicado 2005

Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas

por Gallardo, A, Lerma, E, Escuin, D, Tibau, A, Muñoz, J, Ojeda, B, Barnadas, A, Adrover, E, Sánchez-Tejada, L, Giner, D, Ortiz-Martínez, F, Peiró, G
Publicado 2012

Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Cata...

por Font, R, Espinas, J A, Gil-Gil, M, Barnadas, A, Ojeda, B, Tusquets, I, Segui, M A, Margelí, M, Arcusa, A, Prat, A, Garcia, M, Borras, J M
Publicado 2012

BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study

por Barnadas, A., Muñoz, M., Margelí, M., Chacón, J. I., Cassinello, J., Antolin, S., Adrover, E., Ramos, M., Carrasco, E., Jimeno, M. A., Ojeda, B., González, X., González, S., Constenla, M., Florián, J., Miguel, A., Llombart, A., Lluch, A., Ruiz-Borrego, M., Colomer, R., Del Barco, S.
Publicado 2019